The adjustment is made in Step 2 by solving the fixed-point Eqs.
The resulting increases in thickness are always made in step changes using metal sheets of uniform thickness because of the availability of such source materials.
Secondly, a declaration of the non-redundant raster search point set P, which is initially set to be empty, is made in step 2. In step 3, each raster region is considered sequentially such that for every point p generated in the current region, this point is searched to determine whether it is stored in the previously examined raster regions or not.
Step 3 does a fine-scale phylogenetic analysis within the taxonomic group identified in Step 2. Since the assignments made in Step 2 are sometimes inaccurate at the low taxonomic level (e.g. genus level), by default the analysis in Step 3 starts with all the sequences from the taxonomic group at the next higher level.
The pharmacist or GP discusses the action plan, made in step 3, with the patient.
Actions made in step 4 are evaluated at an agreed time interval with the pharmacist and/or GP.
We used the standard AHP weighted averaging method to combine the results of the judgments made in step three to determine the relative abilities of the management options to meet the goal for each of the four clinical scenarios.
If ξ k + 1= ξ k (no change has been made in step 4), update the temperature according to a geometric cooling scheme: T k + 1= r T k.
We will use the standard AHP weighting to combine the results of the judgments made in step three to determine the relative abilities of the medications to meet our stated goals for the decision context.
Similarly, in step 4, the authors state that they will "…use the standard AHP weighting to combine the results and judgements made in step three to determine relative abilities of the medications to meet our stated goals for decision contexts ".
